Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Determine Protective Efficacy Against Otitis Media and Assess Safety of an Investigational Pneumococcal Vaccine 2189242A in Healthy Infants

NCT01545375 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01545375
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01545375 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Determine Protective Efficacy Against Otitis Media and Assess Safety of an Investigational Pneumococcal Vaccine 2189242A in Healthy Infants
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
May 21, 2012
Completion date
July 26, 2016
Enrollment
1,806 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

infections, streptococcal